Treatments for COVID-19: emerging drugs against the coronavirus - reply.
作者信息
Potì Francesco
机构信息
Dipartimento di Medicina e Chirurgia - Unità di Neuroscienze dell'Università di Parma.
出版信息
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
Abstract
摘要
相似文献
1
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
2
Treatments for COVID-19: emerging drugs against the coronavirus.新冠病毒病的治疗方法：对抗冠状病毒的新型药物
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
3
Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.回复信 - 2019冠状病毒病（新型冠状病毒2019） - 近期趋势
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6482-6483. doi: 10.26355/eurrev_202006_21629.
4
Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".对《2019冠状病毒病（COVID-19）：对临床牙科护理的影响》的回复
J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
5
Reply to "Opening Up Resident Education During the Coronavirus Disease (COVID-19) Pandemic and Beyond".对《在冠状病毒病（COVID-19）大流行期间及之后开放住院医师教育》的回复
AJR Am J Roentgenol. 2020 Oct;215(4):W49. doi: 10.2214/AJR.20.23881. Epub 2020 Jul 29.
6
Reply to "On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic".对《胸部X线摄影和CT在冠状病毒病（COVID-19）大流行中的作用》的回复
AJR Am J Roentgenol. 2020 Oct;215(4):W45. doi: 10.2214/AJR.20.24159. Epub 2020 Jul 22.
7
In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".致编辑的信的回复，主题为“冠状病毒病（COVID-19）的神经学影响：神经科学界的实际考量” 。
World Neurosurg. 2020 Oct;142:535-536. doi: 10.1016/j.wneu.2020.06.115. Epub 2020 Jun 23.
8
Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History: Authors' Reply.儿童冠状病毒病-19（COVID-19）：文献荟萃分析与自然史：作者回复
Indian Pediatr. 2020 Sep 15;57(9):870. doi: 10.1007/s13312-020-1978-4.
9
Reply to "Critical Review of the Literature on Chest CT and Coronavirus Disease (COVID-19): Data Adjustment".对《胸部CT与冠状病毒病（COVID-19）文献的批判性综述：数据调整》的回复
AJR Am J Roentgenol. 2020 Aug;215(2):W28. doi: 10.2214/AJR.20.23564. Epub 2020 Jun 1.
10
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.2019冠状病毒病（COVID-19）：口腔医学面临的新出现和未来挑战
J Dent Res. 2020 Aug;99(9):1113. doi: 10.1177/0022034520932149. Epub 2020 May 28.
本文引用的文献
1
Treatments for COVID-19: emerging drugs against the coronavirus.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新兴药物。
Acta Biomed. 2020 May 11;91(2):118-136. doi: 10.23750/abm.v91i2.9639.
2
First-line drugs for hypertension.高血压一线用药。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.
3
Blood pressure-lowering efficacy of reserpine for primary hypertension.利血平对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD007655. doi: 10.1002/14651858.CD007655.pub3.
4
A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.全激酶组小干扰RNA筛选鉴定出严重急性呼吸综合征冠状病毒复制中的前病毒和抗病毒宿主因子，包括双链RNA激活蛋白激酶和早期分泌途径蛋白。
J Virol. 2015 Aug;89(16):8318-33. doi: 10.1128/JVI.01029-15. Epub 2015 Jun 3.
5
Molecular interactions in the assembly of coronaviruses.冠状病毒组装过程中的分子相互作用。
Adv Virus Res. 2005;64:165-230. doi: 10.1016/S0065-3527(05)64006-7.
6
Small molecules targeting severe acute respiratory syndrome human coronavirus.靶向严重急性呼吸综合征人冠状病毒的小分子
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7. doi: 10.1073/pnas.0403596101. Epub 2004 Jun 28.
7
Aspects of tolerability of centrally acting antihypertensive drugs.中枢性抗高血压药物的耐受性方面。
J Cardiovasc Pharmacol. 1996;27 Suppl 3:S49-54. doi: 10.1097/00005344-199627003-00007.
Zotero 插件